CorTec's implantable Brain Interchange system received FDA Breakthrough Device Designation on April 8 and TAP acceptance on April 23, marking the first BCI worldwide designated for stroke motor rehabilitation.
Intellia Therapeutics will report topline Phase 3 results for lonvoguran ziclumeran in hereditary angioedema on April 27, 2026 — the first Phase 3 readout for any in vivo CRISPR candidate.
Meta's first Oklahoma data center — a 2-million-square-foot AI facility in East Tulsa — was grandfathered past a city moratorium that paused similar projects, drawing local protests.
Elon Musk confirmed on Tesla's Q1 2026 earnings call that roughly 4 million HW3 vehicles cannot run unsupervised FSD, reversing years of promises and triggering legal exposure.
The TOI-201 system hosts a super-Earth, a warm Jupiter, and a record-setting brown dwarf whose gravitational interplay drives orbital shifts observable on human timescales — within 200 years its planets will stop transiting.
The FDA cleared doravirine/islatravir on April 21, completing a development program that was halted in 2021 over lymphocyte counts and restarted at a lower dose.
Six-year follow-up from a 16-patient Phase 1 trial of autogene cevumeran shows unprecedented survival rates in one of oncology's deadliest cancers, now entering a global Phase 2 trial.
OpenAI's first domain-specific model for biology and drug discovery connects to 50+ scientific databases and outperformed human experts on RNA sequence tasks, but faces established rivals and a decade-long clinical validation gap.
At TrailblazerDX 2026, Salesforce unveiled Headless 360, exposing its full platform as APIs, MCP tools, and CLI commands so AI coding agents can build and operate on Salesforce without a browser.
A new GOP-backed bill would create a national consumer privacy framework but preempt stronger state laws like California's CCPA, reigniting a years-long battle over whether federal rules should be a floor or a ceiling.
After years of development, sbt 2.0 has reached RC12 with 60+ ecosystem plugins ported, targeting a stable release within weeks to months.
Three bipartisan Senate bills and a House companion measure introduced in early 2026 would require federal disclosure of AI-related job cuts, fund workforce research, and establish a commission to recommend labor and tax policy changes.